Cite
HARVARD Citation
Amin, A. et al. (2019). Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Journal for immunotherapy of cancer. 7 (1), p. . [Online].